MB
Mesh Bio utilizes predictive analytics to enhance the management of chronic diseases by analyzing patient data to forecast health outcomes. This approach enables healthcare providers to implement timely interventions, improving patient adherence and reducing hospitalizations.
Updated 4 months ago
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Mesh Bio utilizes predictive analytics to enhance the management of chronic diseases by analyzing patient data to forecast health outcomes. This approach enables healthcare providers to implement timely interventions, improving patient adherence and reducing hospitalizations.